Platelet transfusion: A systematic review of the clinical evidence

Transfusion

Volumn 55, Issue 5, 2015, Pages 1116-1127

  Kumar, Ambuj ^a,b   Mhaskar, Rahul ^a   Grossman, Brenda J ^c   Kaufman, Richard M ^d   Tobian, Aaron A R ^e   Kleinman, Steven ^f   Gernsheimer, Terry ^g   Tinmouth, Alan T ^h   Djulbegovic, Benjamin ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF WASHINGTON   (United States)

^h UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CENTRAL VENOUS CATHETER; CHEMOTHERAPY; CORONARY ARTERY BYPASS GRAFT; DISSEMINATED INTRAVASCULAR CLOTTING; HEMATOLOGIC MALIGNANCY; HEMOLYTIC UREMIC SYNDROME; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LUMBAR PUNCTURE; META ANALYSIS (TOPIC); METHODOLOGY; OBSERVATIONAL STUDY; PARACENTESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; THORACOCENTESIS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TRAUMATIC BRAIN INJURY;

HUMANS; PLATELET TRANSFUSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84929179935     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12943     Document Type: Article

References (73)

1. Whitaker B, Hinkins S,. The 2011 national blood collection and utilization survey report. Rockville (MD): US Department of Health and Human Services; 2013.
2. McCullough J,. Overview of platelet transfusion. Semin Hematol 2010;47:235-242.
3. Strauss RG, Blanchette VS, Hume H, et al. National acceptability of American Association of Blood Banks Pediatric Hemotherapy Committee guidelines for auditing pediatric transfusion practices. Transfusion 1993;33:168-171.
4. Higgins JP, Green S, Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 ed. Chichester (UK); Hoboken (NJ): Wiley-Blackwell; 2011.
5. Knobloch K, Yoon U, Vogt PM,. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg 2011;39:91-92.
6. Estcourt L, Stanworth S, Doree C, et al. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev 2012;5:CD004269.
7. Haynes RB, McKibbon KA, Wilczynski NL, et al. Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey. BMJ 2005;330:1179.
8. Stang A,. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603-605.
9. Wells GA, Shea B, Higgins JP, et al. Checklists of methodological issues for review authors to consider when including non-randomized studies in systematic reviews. Res Synth Methods: 2013;4:63-77.
10. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-926.
11. Deeks JJ, Altman DG, Bradburn MJ,. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In:, Egger M, Davey Smith G, Altman DG, editors. Systematic reviews in health care. London: BMJ Publishing Group; 2008. p. 285-312.
12. Stanworth SJ, Estcourt L, Powter G, et al. The effect of a no-prophylactic versus prophylactic platelet transfusion strategy on bleeding in patients with hematological malignancies and severe thrombocytopenia (TOPPS trial). A randomized controlled, non-inferiority trial [abstract]. Blood 2012;120.
13. Wandt H, Schaefer-Eckart K, Wendelin K, et al. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet 2012;380:1309-1316.
14. Murphy S, Litwin S, Herring LM, et al. Indications for platelet transfusion in children with acute leukemia. Am J Hematol 1982;12:347-356.
15. Solomon J, Bofenkamp T, Fahey JL, et al. Platelet prophylaxis in acute non-lymphoblastic leukaemia. Lancet 1978;1:267.
16. Diedrich B, Remberger M, Shanwell A, et al. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 × 10 (9) per L versus 30 × 10 (9) per L in allogeneic hematopoietic progenitor cell transplant recipients. Transfusion 2005;45:1064-1072.
17. Heckman KD, Weiner GJ, Davis CS, et al. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. J Clin Oncol 1997;15:1143-1149.
18. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 1997;337:1870-1875.
19. Zumberg MS, del Rosario ML, Nejame CF, et al. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger. Biol Blood Marrow Transplant 2002;8:569-576.
20. Roy AJ, Jaffe N, Djerassi I,. Prophylactic platelet transfusions in children with acute leukemia: a dose response study. Transfusion 1973;13:283-290.
21. Heddle NM, Cook RJ, Tinmouth A, et al. A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood 2009;113:1564-1573.
22. Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010;362:600-613.
23. Tinmouth A, Tannock IF, Crump M, et al. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design. Transfusion 2004;44:1711-1719.
24. Gross SJ, Filston HC, Anderson JC,. Controlled study of treatment for disseminated intravascular coagulation in the neonate. J Pediatr 1982;100:445-448.
25. Ray CE Jr, Shenoy SS,. Patients with thrombocytopenia: outcome of radiologic placement of central venous access devices. Radiology 1997;204:97-99.
26. Breuer AC, Tyler HR, Marzewski DJ, et al. Radicular vessels are the most probable source of needle-induced blood in lumbar puncture: significance for the thrombocytopenic cancer patient. Cancer 1982;49:2168-2172.
27. Feusner J,. Platelet transfusion "trigger" for lumbar puncture. Pediatr Blood Cancer 2004;43:793.
28. Howard SC, Gajjar A, Ribeiro RC, et al. Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia. JAMA 2000;284:2222-2224.
29. Kitanovski L, Trampus-Bakija A, Benedik-Dolnicar M,. Prophylactic platelet transfusions before lumbar puncture. Zdravniski Vestnik-Slovenian Med J 2008;77:I111-115.
30. Ruell J, Karuvattil R, Wynn R, et al. Platelet count has no influence on traumatic and bloody lumbar puncture in children undergoing intrathecal chemotherapy. Br J Haematol 2007;136:347-348.
31. Vavricka SR, Walter RB, Irani S, et al. Safety of lumbar puncture for adults with acute leukemia and restrictive prophylactic platelet transfusion. Ann Hematol 2003;82:570-573.
32. van Veen JJ,. Lumbar puncture in thrombocytopenic children. Br J Haematol 2004;127:230-239.
33. Palo R, Capraro L, Hanhela R, et al. Platelet transfusions in adult patients with particular reference to patients undergoing surgery. Transfus Med 2010;20:30-37.
34. Bishop JF, Schiffer CA, Aisner J, et al. Surgery in acute leukemia: a review of 167 operations in thrombocytopenic patients. Am J Hematol 1987;26:147-155.
35. Spiess BD, Royston D, Levy JH, et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004;44:1143-1148.
36. Downey DM, Monson B, Butler KL, et al. Does platelet administration affect mortality in elderly head-injured patients taking antiplatelet medications? Am Surg 2009;75:1100-1103.
37. Ivascu FA, Howells GA, Junn FS, et al. Predictors of mortality in trauma patients with intracranial hemorrhage on preinjury aspirin or clopidogrel. J Trauma 2008;65:785-788.
38. Ohm C, Mina A, Howells G, et al. Effects of antiplatelet agents on outcomes for elderly patients with traumatic intracranial hemorrhage. J Trauma 2005;58:518-522.
39. Wong DK, Lurie F, Wong LL,. The effects of clopidogrel on elderly traumatic brain injured patients. J Trauma 2008;65:1303-1308.
40. Fortuna GR, Mueller EW, James LE, et al. The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury. Surgery 2008;144:598-603. discussion 603-5.
41. Washington CW, Schuerer DJ, Grubb RL Jr,. Platelet transfusion: an unnecessary risk for mild traumatic brain injury patients on antiplatelet therapy. J Trauma 2011;71:358-363.
42. Creutzfeldt CJ, Weinstein JR, Longstreth WT Jr,., et al. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage. J Stroke Cerebrovasc Dis 2009;18:221-228.
43. Ducruet AF, Hickman ZL, Zacharia BE, et al. Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage. Neurol Res 2010;32:706-710.
44. Anglin CO, Spence JS, Warner MA, et al. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses. J Neurosurg 2013;118:676-686.
45. Duffy SM, Coyle TE,. Platelet transfusions and bleeding complications associated with plasma exchange catheter placement in patients with presumed thrombotic thrombocytopenic purpura. J Clin Apher 2013;28:356-358.
46. Swisher KK, Terrell DR, Vesely SK, et al. Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion 2009;49:873-887.
47. Kennedy KA, Vesely SK, George JN,. The potential risks of platelet transfusions (PT) in patients with thrombotic thrombocytopenia purpura-hemolytic uremic syndrome (TTP-HUS). Blood 2000;96(11 part 1):631a, Ember 16.
48. McVay PA, Toy PT,. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion 1991;31:164-171.
49. Barrera R, Mina B, Huang Y, et al. Acute complications of central line placement in profoundly thrombocytopenic cancer patients. Cancer 1996;78:2025-2030.
50. Doerfler ME, Kaufman B, Goldenberg AS,. Central venous catheter placement in patients with disorders of hemostasis. Chest 1996;110:185-188.
51. Fisher NC, Mutimer DJ,. Central venous cannulation in patients with liver disease and coagulopathy-a prospective audit. Intensive Care Med 1999;25:481-485.
52. Haas B, Chittams JL, Trerotola SO,. Large-bore tunneled central venous catheter insertion in patients with coagulopathy. J Vasc Interv Radiol 2010;21:212-217.
53. Mumtaz H, Williams V, Hauer-Jensen M, et al. Central venous catheter placement in patients with disorders of hemostasis. Am J Surg 2000;180:503-505. discussion 506.
54. Stecker MS, Johnson MS, Ying J, et al. Time to hemostasis after traction removal of tunneled cuffed central venous catheters. J Vasc Interv Radiol 2007;18:1232-1239. quiz 1240.
55. Zeidler K, Arn K, Senn O, et al. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia. Transfusion 2011;51:2269-2276.
56. Sintnicolaas K, Velden K, Sizoo W, et al. Comparison of "prophylactic" and "therapeutic" single-donor platelet transfusions in patients with acute leukemia. Br J Haematol 1981;50:684.
57. Sensebe L, Giraudeau B, Bardiaux L, et al. The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study. Blood 2005;105:862-864.
58. Naidech AM, Liebling SM, Rosenberg NF, et al. Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage. Neurocrit Care 2012;16:82-87.
59. Naidech AM, Jovanovic B, Liebling S, et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke 2009;40:2398-2401.
60. Tran L, Goel R, Krishnamurti L,. Platelet transfusions in patients with immune thrombocytopenic purpura (ITP)-evaluation of the current nationwide inpatient hospital practices. Blood 2010;116:1558.
61. Wu Z, Zhou J, Li J, et al. The feasibility of laparoscopic splenectomy for ITP patients without preoperative platelet transfusion. Hepatogastroenterology 2012;59:81-85.
62. Chen X, Peng B, Cai Y, et al. Laparoscopic splenectomy for patients with immune thrombocytopenia and very low platelet count: is platelet transfusion necessary? J Surg Res 2011;170:e225-232.
63. Carr JM, Kruskall MS, Kaye JA, et al. Efficacy of platelet transfusions in immune thrombocytopenia. Am J Med 1986;80:1051-1054.
64. Ferrara M, Capozzi L, Coppola A, et al. Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review. Hematology 2007;12:297-299.
65. So MY, Li CH, Lee AC, et al. Intracranial haemorrhage among Chinese children with immune thrombocytopenia in a Hong Kong regional hospital. Hong Kong Med J 2013;19:129-134.
66. Spahr JE, Rodgers GM,. Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: a retrospective review of 40 patients. Am J Hematol 2008;83:122-125.
67. Salama A, Kiesewetter H, Kalus U, et al. Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia. Thromb Haemost 2008;100:762-765.
68. Blood transfusion guideline. Utrecht, The Netherlands: Dutch Institute for Healthcare Improvement CBO; 2011.
69. Lieberman L, Bercovitz RS, Sholapur NS, et al. Platelet transfusions for critically ill patients with thrombocytopenia. Blood 2014;123:1146-1151.
70. Hogshire LC, Patel MS, Rivera E, et al. Evidence review: periprocedural use of blood products. J Hosp Med 2013;8:647-652.
71. Carson JL, Grossman BJ, Kleinman S, et al., for the Clinical Transfusion Medicine Committee of the AABB. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012;157:49-58.
72. Roback JD, Caldwell S, Carson J, et al. Evidence-based practice guidelines for plasma transfusion. Transfusion 2010;50:1227-1239.
73. Altman DG, Bland JM,. Statistics notes: absence of evidence is not evidence of absence. BMJ 1995;311:485.